Pharmacy benefit managers are facing more pressure after the Department of Labor issued new requirements for disclosing their financial dealings with drugmakers, pharmacies and others health system players. The proposed rule stems from President Trump’s executive order on lowering drug prices and comes as Congress is targeting the drug supply intermediaries with more transparency rules. PBMs like CVS Caremark, Express Scripts and Optum Rx would have to make semiannual disclosures to employers of what they earn for negotiating drug prices on behalf of health plans.
Read the full article: PBMs Hit by Trump Transparency Rule //
Source: https://www.axios.com/2026/02/02/pbm-trump-transparency-rule